These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 8431557

  • 1. Pilot study of anti-lipopolysaccharide human monoclonal antibody MAB-T88 in patients with gram-negative sepsis.
    Daifuku R, Panacek EA, Haenftling K, Swenson WK, Prescott AW, Johnson JL.
    Hum Antibodies Hybridomas; 1993 Jan; 4(1):36-9. PubMed ID: 8431557
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Anti-lipopolysaccharide and anti-tumor necrosis factor/cachectin antibodies for the treatment of gram-negative bacteremia and septic shock.
    Calandra T, Baumgartner JD, Glauser MP.
    Prog Clin Biol Res; 1991 Jan; 367():141-59. PubMed ID: 1924424
    [Abstract] [Full Text] [Related]

  • 4. The role of monoclonal antibodies in the management of gram-negative sepsis. Experience with the E5 antibody.
    Gorelick KJ, Chmel H.
    Infect Dis Clin North Am; 1991 Dec; 5(4):899-913. PubMed ID: 1783775
    [Abstract] [Full Text] [Related]

  • 5. Gram-negative sepsis, the sepsis syndrome, and the role of antiendotoxin monoclonal antibodies.
    Barriere SL, Guglielmo BJ.
    Clin Pharm; 1992 Mar; 11(3):223-35. PubMed ID: 1611812
    [Abstract] [Full Text] [Related]

  • 6. Projected impact of monoclonal anti-endotoxin antibody therapy.
    Bates DW, Lee TH.
    Arch Intern Med; 1994 Jun 13; 154(11):1241-9. PubMed ID: 8203991
    [Abstract] [Full Text] [Related]

  • 7. Anti-lipopolysaccharide antibodies in gram-negative bacteremia.
    Baumgartner JD.
    Behring Inst Mitt; 1991 Feb 13; (88):216-21. PubMed ID: 2049041
    [Abstract] [Full Text] [Related]

  • 8. Immunization with antibodies that mimic LPS protects against gram negative bacterial sepsis.
    Klaerner HG, Dahlberg PS, Acton RD, Battafarano RJ, Uknis ME, Johnston JW, Dunn DL.
    J Surg Res; 1997 May 13; 69(2):249-54. PubMed ID: 9224390
    [Abstract] [Full Text] [Related]

  • 9. Generation of a protective human monoclonal for the treatment of gram-negative sepsis.
    Larrick JW, Gray O, Deinhart T, Wang J, Flatgaard J, Chong KT.
    Prog Clin Biol Res; 1988 May 13; 272():383-93. PubMed ID: 3393571
    [Abstract] [Full Text] [Related]

  • 10. Update on monoclonal antibody therapy in the gram-negative sepsis syndrome.
    Hecker RB.
    J Am Osteopath Assoc; 1992 Aug 13; 92(8):1017-20. PubMed ID: 1429060
    [Abstract] [Full Text] [Related]

  • 11. Life-saving immunotherapy with cross-reactive monoclonal antibodies against endotoxin: a critical evaluation of experimental and clinical studies.
    Cornelissen JJ, Schellekens JF, Kraaijeveld CA, Verhoef J.
    Neth J Med; 1991 Oct 13; 39(3-4):170-6. PubMed ID: 1791879
    [Abstract] [Full Text] [Related]

  • 12. HA-1A. A human monoclonal antibody for the treatment of gram-negative sepsis.
    Smith CR, Straube RC, Ziegler EJ.
    Infect Dis Clin North Am; 1992 Mar 13; 6(1):253-66. PubMed ID: 1578120
    [Abstract] [Full Text] [Related]

  • 13. Immunotherapy with antibodies to core lipopolysaccharide: a critical appraisal.
    Baumgartner JD.
    Infect Dis Clin North Am; 1991 Dec 13; 5(4):915-27. PubMed ID: 1723740
    [Abstract] [Full Text] [Related]

  • 14. [Cytokines and septic shock. New perspectives on its treatment].
    Zamora Madaria E.
    An Med Interna; 1993 Dec 13; 10(12):573-5. PubMed ID: 8049320
    [No Abstract] [Full Text] [Related]

  • 15. Adoptive immunotherapy of gram-negative sepsis: use of monoclonal antibodies to lipopolysaccharide.
    Fink MP.
    Crit Care Med; 1993 Feb 13; 21(2 Suppl):S32-9. PubMed ID: 8428494
    [Abstract] [Full Text] [Related]

  • 16. Monoclonal antibodies to endotoxin in the management of sepsis.
    Fang KC.
    West J Med; 1993 Apr 13; 158(4):393-9. PubMed ID: 8317126
    [Abstract] [Full Text] [Related]

  • 17. Randomized, double-blind phase II study of anti-endotoxin antibody (E5) as adjuvant therapy in humans with serious gram-negative infections.
    Greenberg RN, Wilson KM, Kunz AY, Wedel NI, Gorelick KJ.
    Prog Clin Biol Res; 1991 Apr 13; 367():179-86. PubMed ID: 1924426
    [Abstract] [Full Text] [Related]

  • 18. [Monoclonal anti-endotoxin antibodies in the treatment of patients with sepsis due to Gram-negative bacteria].
    Speelman P, van Deventer SJ.
    Ned Tijdschr Geneeskd; 1991 May 18; 135(20):877-8. PubMed ID: 2046787
    [No Abstract] [Full Text] [Related]

  • 19. Detection of circulating lipopolysaccharide-bound monocytes in children with gram-negative sepsis.
    Takeshita S, Nakatani K, Tsujimoto H, Kawamura Y, Sekine I.
    J Infect Dis; 2000 Nov 18; 182(5):1549-52. PubMed ID: 11015235
    [Abstract] [Full Text] [Related]

  • 20. [Monoclonal antibodies in the treatment of sepsis caused by Gram-negative microorganisms].
    Otero AJ, Linares M.
    Rev Cubana Med Trop; 1998 Nov 18; 50(1):31-5. PubMed ID: 9842265
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.